Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Collegium Pharma (NQ: COLL ) 39.21 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Collegium Pharma < Previous 1 2 3 4 Next > S&P Global To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday September 05, 2024 Via Benzinga Topics Stocks Exposures US Equities The Analyst Landscape: 4 Takes On Collegium Pharmaceutical September 05, 2024 Via Benzinga Collegium Completes Acquisition of Ironshore Therapeutics September 04, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Dr. Reddy's Stock Hit All-Time High Last Month. Ready To Climb Again? September 03, 2024 Dr. Reddy's Labs sees its Relative Strength Rating enter the 80-plus level. Via Investor's Business Daily Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference August 30, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire The Analyst Verdict: Collegium Pharmaceutical In The Eyes Of 4 Experts August 09, 2024 Via Benzinga Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024 August 28, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Organon Stock Sees Relative Strength Rating Rise To 91 August 27, 2024 On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before. Via Investor's Business Daily Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold August 20, 2024 On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier. Via Investor's Business Daily COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Collegium Reports Second Quarter 2024 Financial Results August 08, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews May 10, 2024 Via Benzinga Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know April 11, 2024 Via Benzinga In a market where value is scarce, NASDAQ:COLL offers a refreshing opportunity with its solid fundamentals. August 06, 2024 COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is probably undervalued for the fundamentals it is displaying. Via Chartmill Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology July 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024 July 25, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire NASDAQ:COLL is an undervalued gem with solid fundamentals. July 16, 2024 COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is probably undervalued for the fundamentals it is displaying. Via Chartmill Dr. Reddy's Labs Stock Sees Improved Technical Strength June 28, 2024 On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76. Via Investor's Business Daily 7 Biotech Stocks to Buy on the Dip: June 2024 June 24, 2024 With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation. Via InvestorPlace NASDAQ:COLL appears to be flying under the radar despite its strong fundamentals. June 24, 2024 COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is an undervalued gem with solid fundamentals. Via Chartmill Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise June 13, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in Jefferies Global Healthcare Conference May 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces $35 Million Accelerated Share Repurchase Program May 13, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Collegium Reports First Quarter 2024 Financial Results May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces CEO Transition May 09, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER April 29, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Report First Quarter 2024 Financial Results on May 9, 2024 April 25, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026 April 11, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference April 03, 2024 From Collegium Pharmaceutical, Inc. Via GlobeNewswire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.